Apellis Pharmaceuticals Expands Leadership Team, Appoints Lucia Celona as Chief People Officer July 22, 2019
Adaptimmune Has Initiated a Radiation Sub-Study to Enhance Antitumor Activity Seen With ADP-A2M4 in Collaboration with The MD Anderson Cancer Center July 22, 2019
Apellis Pharmaceuticals Will Commence APL-9 Program to Control the Complement System in Host Responses to AAV Vector Administration for Gene Therapies July 18, 2019
TraceLink Partners With Excellis to Provide Local Implementation Services for its Russia Compliance Solution Through One Global Compliance Platform July 18, 2019
Precision BioSciences Opens First In-House cGMP Manufacturing Facility Dedicated to Genome-Edited Allogeneic CAR T Cell Therapy in the United States July 18, 2019
Adaptimmune Starts the SURPASS Clinical Trial with its first Next-Generation SPEAR T-cells Targeting MAGE‑A4 to Enhance Antitumor Responses July 18, 2019
Acacia Pharma Founder Dr. Julian Gilbert steps down – Michael Bolinder, Chief Commercial Officer, becomes CEO in Planned Succession July 18, 2019